Latest filing published 24 Jun 2026 for BridgeBio Pharma, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -57.0%Entry US$16.68 · Close at T+365 US$7.17
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Ronald J. Daniels: trading record in brief
All filings by Ronald J. Daniels on record concern BridgeBio Pharma, Inc., in the capacity of board member. The record holds 7 filings, for trades running from 28 December 2021 to 22 June 2026.
Both buying and selling appear: 2 purchases worth €263k, against 2 sales worth €3.5M. Netting one side against the other leaves €3.3M of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 share grants and 1 option exercise.
Most recently, on 24 June 2026, the filings show a share grant in BridgeBio Pharma, Inc. The latest purchase dates back some time: it was published 1,775 days ago, on 30 December 2021. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Ronald J. Daniels
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,990 sharesCommon StockSEC:0001470831-26-000631:0
- 61,031 shares@ US$63.7260.2% of flowCommon StockSEC:0001470831-25-000297:1
- 61,031 shares@ US$34.6593.3% of flowCommon StockSEC:0001470831-25-000297:0
- 6,589 shares0Common StockSEC:0000950170-25-089666:0
- 11,745 shares@ US$12.805.9% of flowCommon StockSEC:0000899243-21-050130:1
- 10,402 shares@ US$14.345.9% of flowCommon StockSEC:0000899243-21-050130:2Canonical exit: 30 Mar 2022 (T+90)
- 11,745 shares@ US$12.736.7% of flowCommon StockSEC:0000899243-21-050130:0Canonical exit: 28 Mar 2022 (T+90)
7 of 7 declarations
